missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. DCC Antibody (OTI5D10), Novus Biologicals Biologicals™
  7. 30306178

DCC Antibody (OTI5D10), Novus Biologicals Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-44889-30ul

 View more versions of this product

Product Code. 30306178

  • 256.00€ / 30µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

DCC Monoclonal antibody specifically detects DCC in Human,Mouse,Rat samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

DCC
Monoclonal
Unconjugated
PBS (pH 7.3) 1% BSA, 50% glycerol
Mouse
>95%
RUO
Primary
Human, Mouse, Rat
Antibody
IgG1
Western Blot
OTI5D10
Western Blot 1:2000
Colorectal cancer suppressor, CRC18, CRCR1, deleted in colorectal cancer protein, deleted in colorectal carcinoma, IGDCC1colorectal tumor suppressor, Immunoglobulin superfamily DCC subclass member 1, immunoglobulin superfamily, DCC subclass, member 1, netrin receptor DCC, Tumor suppressor protein DCC
Full length human recombinant protein of human DCC (NP_005206) produced in HEK293T cell.
30 μL
Apoptosis, Cancer, Tumor Suppressors
1630
Store at -20 degrees C. Avoid freeze/thaw cycles.
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.